Patents by Inventor Vincent Bond

Vincent Bond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trypanosome derived apoptotic factors (TAF)
    Publication number: 20050281827
    Abstract: An antibody was raised against a synthetic 27 per peptide (ProEP2-1) blocked T. brucei and ProEP2-1-induced apoptosis in human brain vascular endothelial cells (HBVEC). The use of this and similar blocking antibodies have use both as diagnostic agents and in treatment to prevent damage arising from infection.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 22, 2005
    Inventors: Jonathan Stiles, Vincent Bond, Michael Powell
  • Modulating vaccine against HIV-1 Nef protein induced lymphocyte depletion
    Publication number: 20050180984
    Abstract: A small peptide of 10 or 11 mers, when linked to an immunogenic moiety, can protect against naferious effects of Nef protein of HIV. The vaccine is not used to induce sterilizing immunity, but to block the ability of soluble Nef protein to induce apoptosis, and to therefore alleviate lymphocyte depletion and organ damage.
    Type: Application
    Filed: January 7, 2005
    Publication date: August 18, 2005
    Inventors: Vincent Bond, Michael Powel, Ming Huang, Cleve James